These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1573 related articles for article (PubMed ID: 29892282)

  • 61. Human UCB-MSCs treatment upon intraventricular hemorrhage contributes to attenuate hippocampal neuron loss and circuit damage through BDNF-CREB signaling.
    Ko HR; Ahn SY; Chang YS; Hwang I; Yun T; Sung DK; Sung SI; Park WS; Ahn JY
    Stem Cell Res Ther; 2018 Nov; 9(1):326. PubMed ID: 30463591
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intraperitoneal administration of mesenchymal stem cells ameliorates acute dextran sulfate sodium-induced colitis by suppressing dendritic cells.
    Nikolic A; Simovic Markovic B; Gazdic M; Randall Harrell C; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; L Lukic M; Stojkovic M; Volarevic V
    Biomed Pharmacother; 2018 Apr; 100():426-432. PubMed ID: 29471245
    [TBL] [Abstract][Full Text] [Related]  

  • 63. TGF-β secreted by human umbilical cord blood-derived mesenchymal stem cells ameliorates atopic dermatitis by inhibiting secretion of TNF-α and IgE.
    Park HH; Lee S; Yu Y; Yoo SM; Baek SY; Jung N; Seo KW; Kang KS
    Stem Cells; 2020 Jul; 38(7):904-916. PubMed ID: 32277785
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human umbilical cord blood mesenchymal stem cells expansion via human fibroblast-derived matrix and their potentials toward regenerative application.
    Van SY; Noh YK; Kim SW; Oh YM; Kim IH; Park K
    Cell Tissue Res; 2019 May; 376(2):233-245. PubMed ID: 30610451
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease.
    Jang YK; Kim M; Lee YH; Oh W; Yang YS; Choi SJ
    Cytotherapy; 2014 Mar; 16(3):298-308. PubMed ID: 24418403
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis.
    Yu Y; Song EM; Lee KE; Joo YH; Kim SE; Moon CM; Kim HY; Jung SA; Jo I
    PLoS One; 2017; 12(8):e0183141. PubMed ID: 28854223
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Repeated injections of human umbilical cord blood-derived mesenchymal stem cells significantly promotes functional recovery in rabbits with spinal cord injury of two noncontinuous segments.
    Yang C; Wang G; Ma F; Yu B; Chen F; Yang J; Feng J; Wang Q
    Stem Cell Res Ther; 2018 May; 9(1):136. PubMed ID: 29751769
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice.
    Banerjee A; Bizzaro D; Burra P; Di Liddo R; Pathak S; Arcidiacono D; Cappon A; Bo P; Conconi MT; Crescenzi M; Pinna CM; Parnigotto PP; Alison MR; Sturniolo GC; D'Incà R; Russo FP
    Stem Cell Res Ther; 2015 Apr; 6(1):79. PubMed ID: 25890182
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
    Kim DH; Lee D; Lim H; Choi SJ; Oh W; Yang YS; Chang JH; Jeon HB
    Biochem Biophys Res Commun; 2018 Oct; 504(4):933-940. PubMed ID: 30224067
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction.
    Cho HM; Kim PH; Chang HK; Shen YM; Bonsra K; Kang BJ; Yum SY; Kim JH; Lee SY; Choi MC; Kim HH; Jang G; Cho JY
    Stem Cells Transl Med; 2017 Mar; 6(3):1040-1051. PubMed ID: 28186692
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells.
    Kang SG; Jeun SS; Lim JY; Kim SM; Yang YS; Oh WI; Huh PW; Park CK
    Childs Nerv Syst; 2008 Mar; 24(3):293-302. PubMed ID: 17968556
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mesenchymal Stem Cell Capping on ECM-Anchored Caspase Inhibitor-Loaded PLGA Microspheres for Intraperitoneal Injection in DSS-Induced Murine Colitis.
    Pathak S; Regmi S; Shrestha P; Choi I; Doh KO; Jeong JH
    Small; 2019 Jun; 15(23):e1901269. PubMed ID: 31018047
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo.
    Lee M; Jeong SY; Ha J; Kim M; Jin HJ; Kwon SJ; Chang JW; Choi SJ; Oh W; Yang YS; Kim JS; Jeon HB
    Biochem Biophys Res Commun; 2014 Apr; 446(4):983-9. PubMed ID: 24657442
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas.
    Kim SM; Kim DS; Jeong CH; Kim DH; Kim JH; Jeon HB; Kwon SJ; Jeun SS; Yang YS; Oh W; Chang JW
    Biochem Biophys Res Commun; 2011 Apr; 407(4):741-6. PubMed ID: 21439934
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity.
    Yabana T; Arimura Y; Tanaka H; Goto A; Hosokawa M; Nagaishi K; Yamashita K; Yamamoto H; Adachi Y; Sasaki Y; Isobe M; Fujimiya M; Imai K; Shinomura Y
    J Pathol; 2009 Jul; 218(3):350-9. PubMed ID: 19291714
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice.
    An JH; Park H; Song JA; Ki KH; Yang JY; Choi HJ; Cho SW; Kim SW; Kim SY; Yoo JJ; Baek WY; Kim JE; Choi SJ; Oh W; Shin CS
    Tissue Eng Part A; 2013 Mar; 19(5-6):685-96. PubMed ID: 23215868
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combinatorial effects of conception and governor vessel electroacupuncture and human umbilical cord blood-derived mesenchymal stem cells on pathomorphologic lesion and cellular apoptosis in rats with cerebral ischemia/reperfusion.
    Yang Z; Chen P; Yu H; Luo W; Pi M; Wu Y; Wang L; Yang F; Gou Y
    J Tradit Chin Med; 2013 Dec; 33(6):779-86. PubMed ID: 24660611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.